Schrag D - Search Results

1

A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic.

Chiao EY, Krown SE, Stier EA, Schrag D. Chiao EY, et al. Among authors: schrag d. J Acquir Immune Defic Syndr. 2005 Dec 1;40(4):451-5. doi: 10.1097/01.qai.0000159669.80207.12. J Acquir Immune Defic Syndr. 2005. PMID: 16280701

2

Squamous-cell carcinoma of the rectum: a rare but curable tumor.

Nahas CS, Shia J, Joseph R, Schrag D, Minsky BD, Weiser MR, Guillem JG, Paty PB, Klimstra DS, Tang LH, Wong WD, Temple LK. Nahas CS, et al. Among authors: schrag d. Dis Colon Rectum. 2007 Sep;50(9):1393-400. doi: 10.1007/s10350-007-0256-z. Dis Colon Rectum. 2007. PMID: 17661147

3

Squamous-cell carcinoma of the anal canal: predictors of treatment outcome.

Roohipour R, Patil S, Goodman KA, Minsky BD, Wong WD, Guillem JG, Paty PB, Weiser MR, Neuman HB, Shia J, Schrag D, Temple LK. Roohipour R, et al. Among authors: schrag d. Dis Colon Rectum. 2008 Feb;51(2):147-53. doi: 10.1007/s10350-007-9125-z. Epub 2008 Jan 8. Dis Colon Rectum. 2008. PMID: 18180997

4

Age and adjuvant chemotherapy use after surgery for stage III colon cancer.

Schrag D, Cramer LD, Bach PB, Begg CB. Schrag D, et al. J Natl Cancer Inst. 2001 Jun 6;93(11):850-7. doi: 10.1093/jnci/93.11.850. J Natl Cancer Inst. 2001. PMID: 11390534

5

The influence of hospital volume on survival after resection for lung cancer.

Bach PB, Cramer LD, Schrag D, Downey RJ, Gelfand SE, Begg CB. Bach PB, et al. Among authors: schrag d. N Engl J Med. 2001 Jul 19;345(3):181-8. doi: 10.1056/NEJM200107193450306. N Engl J Med. 2001. PMID: 11463014 Free article.

6

Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare.

Schrag D, Gelfand SE, Bach PB, Guillem J, Minsky BD, Begg CB. Schrag D, et al. J Clin Oncol. 2001 Sep 1;19(17):3712-8. doi: 10.1200/JCO.2001.19.17.3712. J Clin Oncol. 2001. PMID: 11533092

7

Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection.

Schrag D, Panageas KS, Riedel E, Hsieh L, Bach PB, Guillem JG, Begg CB. Schrag D, et al. J Surg Oncol. 2003 Jun;83(2):68-78; discussion 78-9. doi: 10.1002/jso.10244. J Surg Oncol. 2003. PMID: 12772198

8

The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma.

Rizk NP, Bach PB, Schrag D, Bains MS, Turnbull AD, Karpeh M, Brennan MF, Rusch VW. Rizk NP, et al. Among authors: schrag d. J Am Coll Surg. 2004 Jan;198(1):42-50. doi: 10.1016/j.jamcollsurg.2003.08.007. J Am Coll Surg. 2004. PMID: 14698310

9

Use of surgery among elderly patients with stage IV colorectal cancer.

Temple LK, Hsieh L, Wong WD, Saltz L, Schrag D. Temple LK, et al. Among authors: schrag d. J Clin Oncol. 2004 Sep 1;22(17):3475-84. doi: 10.1200/JCO.2004.10.218. J Clin Oncol. 2004. PMID: 15337795

10

Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population.

Schrag D, Mitra N, Xu F, Rabbani F, Bach PB, Herr H, Begg CB. Schrag D, et al. Urology. 2005 Jun;65(6):1118-25. doi: 10.1016/j.urology.2004.12.029. Urology. 2005. PMID: 15922428

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

455 results

Search Page

Filters